Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. | Int J Mol Sci | 2021 | 34769503 | PubTator, text mining | PubMed |
| Modeling the ACVR1R206H mutation in human skeletal muscle stem cells. | Elife | 2021 | 34755602 | PubTator, text mining | PubMed |
| The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma - systematic review and discussion of current therapeutic options. | Contemp Oncol (Pozn) | 2021 | 34729042 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression of TGF-β Signaling Regulators and Prognosis in Human Esophageal Cancer. | Comput Math Methods Med | 2021 | 34725559 | PubTator, text mining | PubMed |
| The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-β as a Companion Target for Checkpoint Blockade Immunotherapy. | Front Cell Dev Biol | 2021 | 34722540 | PubTator, text mining | PubMed |
| Comparative genomics reveals molecular mechanisms underlying health and reproduction in cryptorchid mammals. | BMC Genomics | 2021 | 34702182 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies. | Int J Mol Sci | 2021 | 34681879 | PubTator, text mining | PubMed |
| Vaccines for Non-Viral Cancer Prevention. | Int J Mol Sci | 2021 | 34681560 | PubTator, text mining | PubMed |
| Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC. | Biomedicines | 2021 | 34680503 | PubTator, text mining | PubMed |
| The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression? | Front Oncol | 2021 | 34671561 | PubTator, text mining | PubMed |
| Case Report: Immune and Genomic Characteristics Associated With Hyperprogression in a Patient With Metastatic Deficient Mismatch Repair Gastrointestinal Cancer Treated With Anti-PD-1 Antibody. | Front Immunol | 2021 | 34659249 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors. | Molecules | 2021 | 34641454 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. | World J Hepatol | 2021 | 34630878 | PubTator, text mining | PubMed |
| The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient. | Front Endocrinol (Lausanne) | 2021 | 34630324 | PubTator, text mining | PubMed |
| Molecular predictors of response to pembrolizumab in thymic carcinoma. | Cell Rep Med | 2021 | 34622229 | PubTator, text mining | PubMed |
| A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs. | Oncotarget | 2021 | 34611474 | PubTator, text mining | PubMed |
| LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway. | Cell Death Discov | 2021 | 34608127 | PubTator, text mining | PubMed |
| Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors. | J Immunother Cancer | 2021 | 34607897 | PubTator, text mining | PubMed |
| Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy. | Sci Rep | 2021 | 34593914 | PubTator, text mining | PubMed |
| A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma. | JTO Clin Res Rep | 2021 | 34589975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers?page=24